Functional Characterization of CLPTM1L as a Lung Cancer Risk Candidate Gene in the 5p15.33 Locus
Michael A. James(Harvard University), Ming You(Houston Methodist), John D. Minna(Center for Neuro-Oncology), Kevin R. Coombes(The University of Texas MD Anderson Cancer Center), Lauren A. Byers(The University of Texas MD Anderson Cancer Center), Weidong Wen(Washington University in St. Louis), Luc Girard(The University of Texas Southwestern Medical Center), Yian Wang(Hunan Normal University), John V. Heymach(The University of Texas MD Anderson Cancer Center)
Cited by 102
Related Papers
TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth
|Cell|2006|1.4k
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
|Journal of Clinical Oncology|2019|1.3k
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study
|The Lancet Oncology|2016|1.1k
High-throughput oncogene mutation profiling in human cancer
|Nature Genetics|2007|996